OTC Drugmaker CoLabs Int'l Withdraws IPO Filing
By Ben Glickman CoLabs Int'l, which develops technology to make over-the-counter drugs, has requested the withdrawal of its initial public offering filing....
Ben Glickman Quantasphere Technology Exchange Commission Labs Int L Nasdaq Capital Market Article Normal
Source: marketwatch.com